The PAX3-FOXO1 fusion gene reduces cell–ECM interactions and TGFβ signaling in rhabdomyosarcoma
We identify downregulation of genes related to cell-ECM interactions and TGFβ signaling in FPRMS. We confirm that TGFβ signaling enhances cell-ECM interactions in FNRMS, utilizing confocal reflection microscopy to assess ECM remodeling, and a live-cell sensor to quantitatively assess TGFβ signaling. We also show that PAX3-FOXO1 increases NOS1 expression, stimulating nitric oxide synthesis, which inhibits TGFβ signaling and reduces cell-ECM interactions. We suggest that PAX3-FOXO1 reprograms ECM anchorage dependence by suppressing cell-ECM interactions. The fusion gene can determine sensitivity to growth inhibition via targeted disruption of cell-ECM interactions or TGFβ signaling. Reduced anchorage reliance by the gene may allow cells to survive in circulation and enhance FPRMS metastatic potential.
Authors
- Sangyoon J. Han (ORCID: https://orcid.org/0000-0002-1384-665X)
- Yuanzhong Pan (ORCID: https://orcid.org/0000-0002-6642-758X)
- JinSeok Park (ORCID: https://orcid.org/0000-0001-6930-895X)
- Vemula Chandra Kaladhar (ORCID: https://orcid.org/0000-0001-6714-2829)
- Ivan Chavez
- Nikhil Mittal (ORCID: https://orcid.org/0000-0001-8499-7749)
- Antonios Chronopoulos
- Vic Zamloot
Institutions
- University of Southern California (US)
- Michigan Technological University (US)
- Children's Hospital of Los Angeles (US)
Publication Details
- Journal
- The Journal of Cell Biology
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1083/jcb.202408155
- Citations
- 2
- Primary Topic
- Renal and related cancers
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Concern Foundation
- Children's Hospital Los Angeles
- National Institutes of Health
- Saban Research Institute